News

BioTrove, Inc. Adds Paul H. Sartori, Ph.D., to Executive Team

BioTrove, Inc. Adds Paul H. Sartori, Ph.D., to Executive Team

Pharma, Biotech Industry Veteran to Support Company Growth, Bolster Managerial Talent as Senior Vice President of Organizational Development and Human Resources

Woburn, MA, September 18, 2007 – BioTrove, Inc. today announced the addition of Paul H. Sartori, Ph.D., as Senior Vice President of Organizational Development and Human Resources. Dr. Sartori brings to BioTrove more than 25 years of leadership experience managing organizational strategy, primarily in the pharmaceutical and diagnostics industries, where he served as a former executive vice president with Novartis and senior counselor to companies including BioMeriux, Focus Diagnostics and Integrated Biosystems.

“Paul’s experience with start-up biotech companies, and notable success developing diagnostic companies for growth, make him perfectly suited to BioTrove’s mission,” said Albert A. Luderer, Ph.D., President and CEO, BioTrove. “At this important time in our company’s development, Paul’s experience and perspective bring immense value to our executive team.”
Dr. Sartori has been a partner at CHM Partners International, LLC, and was previously global VP of Human Resources at CIBA-Corning Diagnostics, Senior Vice President of HR and Communications at CIBA-Geigy and Executive Vice-President, External Affairs and Human Resources at Novartis. He is also a well-known consultant, having worked with various diagnostic and pharmaceutical organizations to improve leadership team and organizational development, and to assist in preparing for IPOs.
“As a company committed to building a major life-sciences enterprise, we welcome the insights Paul will bring to our commercialization and R&D programs,” said Robert H. Ellis, Executive Chairman, BioTrove. “We are proud to attract global best-in-class executives to BioTrove, and Paul’s wealth of experience in the diagnostic and pharmaceutical arena certainly demonstrates the level of professional talent building this company.”
Before joining the life-sciences and pharmaceutical industries, Dr. Sartori held academic teaching and administrative posts at the University of Virginia and James Madison University. He has also served as an advisor to the University of Virginia Partnership for Leaders in Education, sponsored by the Darden Graduate School of Business and the Curry School of Education. He has been a guest speaker at several business schools including Virginia, Cornell University and the University of Capetown.
Dr. Sartori received his M.A.T., Ph.D. and MBA from the University of Virginia and his B.A. from Northeastern University.
About BioTrove, Inc.
BioTrove, Inc. offers two innovative technology platforms: RapidFire™, which enables the acceleration of drug discovery and pipeline decisions, and OpenArray™, which advances genomic research in a wide range of life science fields, including agriculture, disease research, bio-defense, and public health. With more than half of the world’s ten largest pharmaceutical companies as clients, and partnerships with prestigious research and public health centers around the world, BioTrove’s products and services ensure that an industry committed to accuracy and speed can meet business goals.
RapidFire™ Mass Spectrometry (RFMS) uses an innovative microfluidic technology to facilitate analysis at faster than 10 seconds per sample, eliminating the bottleneck created by traditional mass spectrometry throughput. RFMS is routinely used in many applications including the high-throughput screening of previously intractable drug targets, cytochrome P450 inhibition and other ADME assays and directed evolution studies.
The OpenArray™ Platform enables genomics researchers to generate SNP and real time qPCR data in the hundreds of thousands of data points per day, significantly increasing the number of samples analyzed while significantly decreasing the time and cost required. The flexible format and nanoliter scale of the OpenArray™ system allows for easy adjustment of sample and assay numbers, achieving economical, high-throughput genomics.
For more information, please visit www.biotrove.com or contact:
Dr. Albert Luderer, President and CEO BioTrove, Inc.

781-721-3648

info@biotrove.com
Arielle Bernstein Makovsky + Company

212-508-9643

abernstein@makovsky.com

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184